BioLingus

Biotechnology company spearheading the development of oral (specifically, sublingual) delivery of peptides and proteins.

The delivery of peptides or proteins, such as insulin, in a non-invasive way (i.e. without needles or injections) is a very challenging endeavor from a scientific and technical perspective.

Since our inception, company have focused on developing an alternative approach, known as sublingual delivery.

 

_____________________________

The number of employees:

10-50

_____________________________

Headquarters:

Grossmatt 6 CH-6052 Hergiswil NW Switzerland